Showing results (341-350 of 371) with videos related to

Sort By:
Pageof 38
International Journal of Molecular Sciences|October 16, 2024
Comprehensive Catalog of Variants Potentially Associated with Hidradenitis Suppurativa, Including Newly Identified Variants from a Cohort of 100 PatientsKévin Muret, Vincent Le Goff, Claire Dandine-Roulland, et al.
The Pharmacogenomics Journal|December 11, 2013
HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysisE Genin, D-P Chen, S-I Hung, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|February 28, 2002
[Neurofibromatosis 1: recommendations for management]S Pinson, A Créange, S Barbarot, et al.
International Journal of Cancer|September 28, 2002
The kinetics of the visible growth of a primary melanoma reflects the tumor aggressiveness and is an independent prognostic marker: a prospective studyJean Jacques Grob, Marie Aleth Richard, Johany Gouvernet, et al.
The British Journal of Dermatology|December 21, 2016
Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adultsJ Gottlieb, S Ingen-Housz-Oro, M Alexandre, et al.
Orphanet Journal of Rare Diseases|April 12, 2018
Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins)Saskia Ingen-Housz-Oro, Tu-Anh Duong, Benoit Bensaid, et al.
Nature Communications|January 31, 2019
Bisnorgammacerane traces predatory pressure and the persistent rise of algal ecosystems after Snowball EarthLennart M van Maldegem, Pierre Sansjofre, Johan W H Weijers, et al.
Lancet (London, England)|June 5, 2025
Efficacy and safety of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas (KOMET): a multicentre, international, randomised, placebo-controlled, parallel, double-blind, phase 3 studyAlice P Chen, Geraldine O'Sullivan Coyne, Pamela L Wolters, et al.
The British Journal of Dermatology|July 7, 2020
Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testingL Le Cleach, L Dousset, H Assier, et al.
The British Journal of Dermatology|October 25, 2023
A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trialsLaura Fertitta, Christina Bergqvist, Kavita Y Sarin, et al.
Pageof 38